Search

everythinglearnresearchcommunity

for

Search:↓

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

A 3-year-old with vitamin D-resistant rickets and severe hair loss died despite treatment, highlighting the need for improved management of the condition.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Teak is a durable, termite-resistant wood with medicinal benefits.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Microneedling combined with triamcinolone can safely stimulate faster hair regrowth in people with Alopecia Areata.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Isoniazid can rarely cause hair loss, which is reversible after stopping the drug.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Mutations in certain receptors can cause diseases and offer new treatment options.